Industry Outlook 2025: Political Implications for Pharma
Pharmaceutical Technology® spoke with Alexander Seyf, CEO and co-founder of Autolomous, about how the political landscape may impact the pharmaceutical industry.
The fundamentals of healthcare are established and supported in the United States, Alexander Seyf, CEO and co-founder of Autolomous, says, and while the changing political landscape might come with some bumps in the road, he believes the mission to treat patients will continue forward.
“I hope that [politicians realize] they can be one of the customers of the pharma and biotech,” Seyf says. “So, I would say at the core of it, we all are human, and sometimes we need to have a little bit of selfish kind of motivation to do the right thing. So, either we going to see a lot of people who have a higher ground, and they will push the support [of] pharma and biotech forward, or they might have a selfish kind of objective at the end, [which] will yield to a positive result. So, I'm pretty positive, because I believe you can change people, but the system will take longer than four years to change.”
Click the video above to watch the full interview.
About the speaker
Alexander Seyf is CEO and Co-Founder of Autolomous.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
